InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,479.83
(
-0.77%
)
US TECH 100
18,721.20
(
-0.65%
)
Dow Jones
40,412.65
(
-1.05%
)
Brent Oil
80.32
(
-1.47%
)
Bitcoin
63,684.86
(
-1.42%
)
Post# of 3683
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

goupupup

Send PM Follow Ignore
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

goupupup

Re: None

Saturday, 09/05/2020 6:00:10 PM

Saturday, September 05, 2020 6:00:10 PM

Post# of 3683
Athersys has the best opportunity to take a cellular therapy to market in ARDS. They have the most complete data sets in this indication.

1. MUST-ARDS 36 total patients. 26 given MultiStem in ARDS from a variety of causes, 10 placebo

2. ONE-BRIDGE 35 total patients. 20 given MultiStem in ARDS caused by pneumonia, 5 given MultiStem
in COVID ARDS, 10 placebo

3. MACOVIA multiple patients given MultiStem from COVID ARDS

Fast Track in US and Orphan Status in Japan.

Athersys partner Healios about to complete enrollment and file for approval in early 2021
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!